• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木犀草素通过抑制 STAT3 通路抑制肝星状细胞活化。

Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway.

机构信息

Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.

School of Medicine, Alabama College of Osteopathic Medicine, Dothan, AL 36303, USA.

出版信息

Int J Mol Sci. 2018 May 24;19(6):1567. doi: 10.3390/ijms19061567.

DOI:10.3390/ijms19061567
PMID:29795016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6032316/
Abstract

Hepatic stellate cell (HSC) activation is responsible for hepatic fibrogenesis and is associated with an overexpression of transcription 3 (STAT3). Luteolin, a common dietary flavonoid with potent anti-inflammatory properties, has previously demonstrated antifibrogenic properties in HSCs but the mechanism has not been fully elucidated. Activated human and rat hepatic stellate cell lines LX-2 and HSC-T6 were used to study the effects of luteolin on HSCs. Cellular proteins were determined by western blot and immunofluorescence. Cell proliferation was assessed with Alamar Blue assay. Luteolin significantly decreased LX-2 and HSC-T6 cell viability in a time-and-dose-dependent manner, as well as decreased HSC end-products α-smooth muscle actin (α-SMA), collagen I, and fibronectin. Luteolin decreased levels of total and phosphorylated STAT3, suppressed STAT3 nuclear translocation and transcriptional activity, and attenuated expression of STAT3-regulated proteins c-myc and cyclin D1. STAT3 specific inhibitors stattic and SH-4-54 demonstrated similar effects on HSC viability and α-SMA production. In LX-2 and HSC-T6 cells, luteolin demonstrates a potent ability to inhibit hepatic fibrogenesis via suppression of the STAT3 pathway. These results further elucidate the mechanism of luteolin as well as the effect of the STAT3 pathway on HSC activation.

摘要

肝星状细胞 (HSC) 的激活负责肝纤维化的发生,并与转录因子 3 (STAT3) 的过度表达有关。木樨草素是一种常见的具有强大抗炎特性的膳食类黄酮,先前已证明其在 HSCs 中具有抗纤维化特性,但机制尚未完全阐明。我们使用激活的人源和大鼠肝星状细胞系 LX-2 和 HSC-T6 来研究木樨草素对 HSCs 的影响。通过 Western blot 和免疫荧光法测定细胞蛋白。通过 Alamar Blue 测定法评估细胞增殖。木樨草素呈时间和剂量依赖性地显著降低 LX-2 和 HSC-T6 细胞活力,并降低 HSC 终产物α-平滑肌肌动蛋白 (α-SMA)、I 型胶原和纤维连接蛋白。木樨草素降低总 STAT3 和磷酸化 STAT3 的水平,抑制 STAT3 核易位和转录活性,并减弱 STAT3 调节的蛋白 c-myc 和细胞周期蛋白 D1 的表达。STAT3 特异性抑制剂 stattic 和 SH-4-54 对 HSC 活力和α-SMA 产生也具有类似的作用。在 LX-2 和 HSC-T6 细胞中,木樨草素通过抑制 STAT3 通路显示出强大的抑制肝纤维化的能力。这些结果进一步阐明了木樨草素的作用机制以及 STAT3 通路对 HSC 激活的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/20b12cbd2292/ijms-19-01567-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/a32bdd31284d/ijms-19-01567-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/7ce8629ca87e/ijms-19-01567-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/fd7b99b46019/ijms-19-01567-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/b4335d8c5f0b/ijms-19-01567-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/20b12cbd2292/ijms-19-01567-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/a32bdd31284d/ijms-19-01567-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/7ce8629ca87e/ijms-19-01567-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/fd7b99b46019/ijms-19-01567-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/b4335d8c5f0b/ijms-19-01567-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c04d/6032316/20b12cbd2292/ijms-19-01567-g005a.jpg

相似文献

1
Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway.木犀草素通过抑制 STAT3 通路抑制肝星状细胞活化。
Int J Mol Sci. 2018 May 24;19(6):1567. doi: 10.3390/ijms19061567.
2
HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways.HJC0416 通过 STAT3 和 NF-κB 信号通路减轻活化肝星状细胞的纤维化形成
J Surg Res. 2021 May;261:334-342. doi: 10.1016/j.jss.2020.12.045. Epub 2021 Jan 21.
3
Novel Oridonin Analog CYD0682 Inhibits Hepatic Stellate Cell Activation via the Heat Shock Protein 90-Dependent STAT3 Pathway.新型冬凌草甲素类似物 CYD0682 通过热休克蛋白 90 依赖性 STAT3 通路抑制肝星状细胞活化。
J Surg Res. 2024 Jun;298:14-23. doi: 10.1016/j.jss.2023.12.056. Epub 2024 Mar 26.
4
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.木犀草素通过靶向AKT/mTOR/p70S6K和TGFβ/Smad信号通路对肝星状细胞和肝纤维化的抗纤维化作用
Liver Int. 2015 Apr;35(4):1222-33. doi: 10.1111/liv.12638. Epub 2014 Aug 5.
5
Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.虾青素通过抑制肝星状细胞中Smad3的激活来预防转化生长因子β1诱导的促纤维化基因表达。
Biochim Biophys Acta. 2015 Jan;1850(1):178-85. doi: 10.1016/j.bbagen.2014.10.014. Epub 2014 Oct 23.
6
Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.奥曲肽通过抑制 Wnt/β-catenin 信号通路、c-Myc 和细胞周期蛋白 D1 来减轻肝纤维化和肝星状细胞增殖及活化。
Int Immunopharmacol. 2018 Oct;63:183-190. doi: 10.1016/j.intimp.2018.08.005. Epub 2018 Aug 8.
7
Anti-fibrotic effects via regulation of transcription factor Sp1 on hepatic stellate cells.通过调节转录因子Sp1对肝星状细胞产生抗纤维化作用。
Cell Physiol Biochem. 2012;29(1-2):51-60. doi: 10.1159/000337586. Epub 2012 Mar 1.
8
Rosmarinic acid inhibits proliferation and induces apoptosis of hepatic stellate cells.迷迭香酸抑制肝星状细胞增殖并诱导其凋亡。
Biol Pharm Bull. 2011;34(3):343-8. doi: 10.1248/bpb.34.343.
9
(-)-Catechin-7--β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway.(-)-儿茶素-7--β-D-阿比糖苷通过抑制 STAT3 信号通路抑制肝星状细胞激活。
Cells. 2019 Dec 20;9(1):30. doi: 10.3390/cells9010030.
10
TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.瞬时受体电位阳离子通道 7 型(TRPM7)通过 PI3K 和 ERK 通路调节血小板衍生生长因子-BB(PDGF-BB)诱导的肝星状细胞增殖。
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):713-25. doi: 10.1016/j.taap.2013.08.009. Epub 2013 Aug 16.

引用本文的文献

1
Extracellular vesicles: emerging therapeutic agents for liver fibrosis.细胞外囊泡:肝脏纤维化的新兴治疗药物
Extracell Vesicles Circ Nucl Acids. 2025 May 7;6(2):216-244. doi: 10.20517/evcna.2025.08. eCollection 2025.
2
Promoting collagen synthesis: a viable strategy to combat skin ageing.促进胶原蛋白合成:对抗皮肤衰老的可行策略。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2488821. doi: 10.1080/14756366.2025.2488821. Epub 2025 Apr 11.
3
Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action.

本文引用的文献

1
Matrix metalloproteinase functions in hepatic injury and fibrosis.基质金属蛋白酶在肝损伤和纤维化中的作用。
Matrix Biol. 2018 Aug;68-69:452-462. doi: 10.1016/j.matbio.2017.11.011. Epub 2017 Dec 6.
2
Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.通过体外抑制研究探讨对乙酰氨基酚(扑热息痛)与两种黄酮类化合物木犀草素和槲皮素之间的代谢相互作用。
J Pharm Pharmacol. 2017 Dec;69(12):1762-1772. doi: 10.1111/jphp.12812. Epub 2017 Sep 5.
3
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
营养保健品对肝星状细胞激活的抑制作用:重点关注作用机制。
J Food Sci Technol. 2024 Nov;61(11):2046-2056. doi: 10.1007/s13197-024-06002-3. Epub 2024 May 18.
4
Exploring the mechanism of action of Bidens pilosa L. in combating hepatic fibrosis through network pharmacology and molecular docking: An observational study.通过网络药理学和分子对接技术探究三叶鬼针草(Bidens pilosa L.)抗肝纤维化的作用机制:一项观察性研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39725. doi: 10.1097/MD.0000000000039725.
5
Feasibility of the inhibitor development for cancer: A systematic approach for drug design.癌症抑制剂开发的可行性:药物设计的系统方法。
PLoS One. 2024 Aug 22;19(8):e0306632. doi: 10.1371/journal.pone.0306632. eCollection 2024.
6
Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis.循环miR-146b、miR-194和miR-214在肝纤维化中的诊断潜力及致病作用
Noncoding RNA Res. 2023 Jun 26;8(4):471-480. doi: 10.1016/j.ncrna.2023.06.004. eCollection 2023 Dec.
7
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis.载姜黄素的骨髓间充质干细胞来源外泌体:肝纤维化治疗的新策略。
Drug Deliv. 2022 Dec;29(1):3270-3280. doi: 10.1080/10717544.2022.2142700.
8
Identification of Protosappanoside D from and Evaluation of Its Pharmacokinetic, Metabolism and Pharmacological Activity.从 中鉴定Protosappanoside D 及其药代动力学、代谢和药理学活性评价。
Molecules. 2022 Sep 18;27(18):6090. doi: 10.3390/molecules27186090.
9
Ailanthone suppresses the activity of human colorectal cancer cells through the STAT3 signaling pathway.苦木酮通过 STAT3 信号通路抑制人结直肠癌细胞的活性。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5076. Epub 2021 Dec 27.
10
Influence of the Bioactive Diet Components on the Gene Expression Regulation.生物活性饮食成分对基因表达调控的影响。
Nutrients. 2021 Oct 20;13(11):3673. doi: 10.3390/nu13113673.
HLF/IL-6/STAT3 前馈回路驱动肝星状细胞激活以促进肝纤维化。
Gut. 2018 Sep;67(9):1704-1715. doi: 10.1136/gutjnl-2016-313392. Epub 2017 Jul 28.
4
Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells.山奈酚和木犀草素通过抑制肺腺癌A549细胞中的STAT3来降低Claudin-2的表达。
Nutrients. 2017 Jun 13;9(6):597. doi: 10.3390/nu9060597.
5
STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.信号转导和转录激活因子3(STAT3)抑制可抑制肝星状细胞纤维化:HJC0123,一种潜在的肝纤维化治疗药物。
RSC Adv. 2016;6(102):100652-100663. doi: 10.1039/C6RA17459K. Epub 2016 Oct 14.
6
Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation.丝裂原活化蛋白激酶(MAPK)和信号转导与转录激活因子3(STAT3)信号转导通路对于白细胞介素-6(IL-6)依赖的肝星状细胞激活均是必需的。
PLoS One. 2017 May 4;12(5):e0176173. doi: 10.1371/journal.pone.0176173. eCollection 2017.
7
Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway.UBC9的下调通过抑制经典的NF-κB信号通路促进活化的人LX-2肝星状细胞凋亡。
PLoS One. 2017 Mar 30;12(3):e0174374. doi: 10.1371/journal.pone.0174374. eCollection 2017.
8
Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1.木犀草素通过增强信号转导和转录激活因子3(STAT3)与含Src同源2结构域的蛋白酪氨酸磷酸酶-1(SHP-1)的结合,选择性地杀死高度活化的STAT3胃癌细胞。
Cell Death Dis. 2017 Feb 9;8(2):e2612. doi: 10.1038/cddis.2017.38.
9
Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells.木犀草素可降低侵袭性,使信号转导和转录激活因子3(STAT3)信号失活,并逆转白细胞介素-6诱导的胰腺癌细胞上皮-间质转化和基质金属蛋白酶分泌。
Onco Targets Ther. 2015 Oct 19;8:2989-3001. doi: 10.2147/OTT.S91511. eCollection 2015.
10
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition.索拉非尼及其衍生物SC-1通过抑制信号转导和转录激活因子3发挥抗纤维化作用。
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7243-8. doi: 10.1073/pnas.1507499112. Epub 2015 May 26.